Literature DB >> 7675442

I kappa B-alpha-mediated inhibition of nuclear transport and DNA-binding by Rel proteins are separable functions: phosphorylation of C-terminal serine residues of I kappa B-alpha is specifically required for inhibition of DNA-binding.

S Sachdev1, E M Rottjakob, J A Diehl, M Hannink.   

Abstract

I kappa B-alpha inhibits both DNA-binding and nuclear translocation of dimeric Rel complexes that contain either the RelA or c-Rel proteins. These inhibitory functions of I kappa B-alpha proteins are regulated by both constitutive and inducible phosphorylation. We have mapped the constitutive phosphorylation sites of p40, the avian I kappa B-alpha protein, to a C-terminal acidic serine-rich region that contains four serine residues. Deletions or point mutations that significantly alter the overall negatively charged character of this region abolish association of p40 with Rel proteins in vitro. Serine-to-alanine amino acid substitutions in this region modulate the association of p40 with Rel proteins in vitro and abolish p40-mediated inhibition of DNA-binding by c-Rel. Substitution of aspartic acid residues for the phosphorylated serine residues has no effect on p40-mediated inhibition of DNA-binding. In contrast, the C-terminal acidic serine-rich region is not required for p40-mediated inhibition of nuclear translocation of Rel proteins. Our results demonstrate that p40-mediated inhibition of nuclear translocation and inhibition of DNA-binding by Rel proteins are separable functions. Our results suggest that the phosphorylation status of C-terminal serine residues of I kappa B-alpha proteins will be an important aspect of the autoregulatory feedback loop that enforces temporal control of Rel-regulated gene expression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7675442

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  Nuclear import of IkappaBalpha is accomplished by a ran-independent transport pathway.

Authors:  S Sachdev; S Bagchi; D D Zhang; A C Mings; M Hannink
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

2.  Phosphorylation of IkappaBalpha in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability.

Authors:  R Lin; P Beauparlant; C Makris; S Meloche; J Hiscott
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

3.  Loss of IkappaB alpha-mediated control over nuclear import and DNA binding enables oncogenic activation of c-Rel.

Authors:  S Sachdev; M Hannink
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

4.  Distinct domains of IkappaBalpha regulate c-Rel in the cytoplasm and in the nucleus.

Authors:  I Luque; C Gélinas
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

5.  Nuclear localization of IkappaB alpha is mediated by the second ankyrin repeat: the IkappaB alpha ankyrin repeats define a novel class of cis-acting nuclear import sequences.

Authors:  S Sachdev; A Hoffmann; M Hannink
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

6.  Distinct functional properties of IkappaB alpha and IkappaB beta.

Authors:  K Tran; M Merika; D Thanos
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

7.  Basal phosphorylation of the PEST domain in the I(kappa)B(beta) regulates its functional interaction with the c-rel proto-oncogene product.

Authors:  Z L Chu; T A McKinsey; L Liu; X Qi; D W Ballard
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

8.  The reverse two-hybrid system: a genetic scheme for selection against specific protein/protein interactions.

Authors:  C A Leanna; M Hannink
Journal:  Nucleic Acids Res       Date:  1996-09-01       Impact factor: 16.971

9.  PEST-dependent cytoplasmic retention of v-Rel by I(kappa)B-alpha: evidence that I(kappa)B-alpha regulates cellular localization of c-Rel and v-Rel by distinct mechanisms.

Authors:  E M Rottjakob; S Sachdev; C A Leanna; T A McKinsey; M Hannink
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.